Sajal Patel, MD
Pediatric Endocrinology · Birmingham, ALNPI 1497187231
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by BETA Bionics, Inc. at 24.4% of the total. That places this record below the midpoint for pediatric endocrinology clinicians in AL, where the typical reported total is $944.
Across 12 payments — averaging $55.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BETA Bionics, Inc.$161
- Gilead$137
- Ossur Americas, Inc.$123
- Sequel Med Tech, LLC$118
- Novo Nordisk$32
- Xeris Pharmaceuticals, Inc.$27
- plus $63 from 3 others
What the payments were for
- Food & beverage$63496%
- Education$274%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BETA Bionics, Inc. | 2 | $161 |
| Gilead | 2 | $137 |
| Ossur Americas, Inc. | 1 | $123 |
| Sequel Med Tech, LLC | 1 | $118 |
| Novo Nordisk | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $27 |
| Medtronic | 1 | $25 |
| UCB, Inc. | 1 | $20 |
| Merck | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$428
- TWIIST$118
- Veklury$116
How this compares
$661 in reported general payments places this provider in the 40th percentile of 22 pediatric endocrinology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 17 | $17,709 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 12 | $6,998 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $1,863 |
| Estradiol (Twice Weekly)Estradiol | 11 | $1,302 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,217 |
| Spironolactone | 15 | $671 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 11 | $582 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Birmingham
- Ambika AshrafBirmingham$39K
- Mary ScottBirmingham$9K
- Kenneth McCormickBirmingham$2K
- Christy FosterBirmingham$1K
- Hussein Abdul-LatifBirmingham$728
- Giovanna BeauchampBirmingham$716
- Joycelyn AtchisonBirmingham$636
- Jessica SchmittBirmingham$607
- Mary BarrBirmingham$448
- Nicole BarnesBirmingham$309
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.